Dosage Forms & Drug Delivery Systems – Page 29

Microbial Limits Failure during cooling and moulding: packaging integrity and stability justification

Identifying early warning signs of microbial limits failures is crucial for prompt action. Symptoms may manifest as:Click to read the full article.

Sterility Test Failure after packaging change: sampling, filtration, and EM controls

The first indicators of a sterility test failure are often identified during routine quality control assessments or through customer complaints. Recognizing these symptoms is critical for initiating an effective investigation.…

Cleaning Validation Failure in suppository manufacturing: process controls for moulding, filling, and storage

Identifying symptoms of cleaning validation failures is the first step in the investigation process. Common indicators in the manufacturing or laboratory setting may include:Click to read the full article.

Cooling Tunnel Variability during bulk hold: GMP investigation and batch disposition

Identifying symptoms or signals of cooling tunnel variability is essential for timely intervention. Common signals include:Click to read the full article.

Em Excursion during sterile filtration: packaging integrity and CCIT justification

Recognizing early symptoms can significantly reduce the risk of severe quality failures. Common indications of an em excursion during sterile filtration may include:Click to read the full article.

Cleaning Validation Failure in suppository manufacturing: CAPA with effectiveness checks for auditors

Recognizing symptoms or signals of cleaning validation failure is critical for timely interventions. Common indicators may include:Click to read the full article.

Cooling Tunnel Variability after excipient change: manufacturing vs lab root cause decision tree

Identifying signals of cooling tunnel variability is the first crucial step in any investigation. Symptoms may manifest both on the manufacturing floor and in lab tests. Look for the following…

Viscosity Drift during bulk hold: GMP investigation and batch disposition

Symptoms of viscosity drift can be subtle yet significant, often manifesting during routine quality control (QC) checks or batch release tests. Common signals that may indicate viscosity drift include:Click to…

Osmolality Oos during sterile filtration: sampling, filtration, and EM controls

Recognizing symptoms of osmolality OOS is the first step toward a comprehensive investigation. Symptoms typically include:Click to read the full article.

Suppository Deformation during inspection readiness: CAPA with effectiveness checks for auditors

Recognizing the symptoms or signals indicating potential issues with suppository deformation is crucial for prompt action. Symptoms can manifest in various forms, including:Click to read the full article.

Packaging Leakage Complaint in suppository manufacturing: GMP investigation and batch disposition

Identifying symptoms or signals of packaging leakage is the initial step in addressing the complaint. Common indicators of leakage can include:Click to read the full article.

Osmolality Oos after packaging change: FDA-ready investigation report and batch disposition

Identifying initial signals is critical in any deviation investigation. An OOS result for osmolality typically surfaces during routine quality control testing. Symptoms to monitor include:Click to read the full article.